JPRN-UMIN000019011已完成未知
A Study on Predictors of Treatment Response to Sofosbuvir and Ledipasvir Therapy in Patients with genotype 1 Chronic Hepatitis C Virus Infection - Predictor of treatment response to SOF LDV therapy
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University0 个研究点目标入组 260 人开始时间: 2015年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patients with poorly controlled cardiac disease (myocardial infarction, cardiac failure, arrhythmia) 2 Patients with severe hepatic impairment 3 Patients with a history of hypersensitivity to HCV NS5B inhibitors or Ribavirin 4 Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5 Patients deemed unsuitable for study entry by their treating physician 6 Patients with renal dysfunction 7 Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
研究者
相似试验
已完成
不适用
A Study on Predictors of Treatment Response to Sofosbuvir and Ribavirin Therapy in Patients with genotype 2 Chronic Hepatitis C Virus InfectioPatients with genotype 2 HCV infectionJPRN-UMIN000018947Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,260
尚未招募
不适用
Treatment Efficacy and Outcome of treatment of Sofosbuvir/Velpatasvir in Hepatitis C Virus Infection Among Adolescents and Young Adultsadolescents and young adults who have hepatitis C virus infectionHepatitis C virus, adolescents, young adults, sofosbuvir/velpatasvir, efficacy, treatment outcomeTCTR20230610001Research and Developmeny Institute35
已完成
不适用
A Study on Predictors of Treatment Response to ombitasvir/paritaprevir/r combination therapy in Patients with genotype 1 Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000020299Hokkaido University260
已完成
不适用
A Study on Predictors of Treatment Response to Simeprevir, Peg-interferon and Ribavirin combination therapyin Patients with genotype Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000020295Hokkaido University200
招募中
不适用
A prospective study of treatment response of patients with myelofibrosis and PNH type blood cellsmyelofibrosisJPRN-UMIN000045859Juntendo University100